Skip to main content

ADVERTISEMENT

Matthieu Godin, MD

03/28/2019
Prolonged dual-antiplatelet therapy in high bleeding risk (HBR) patients undergoing percutaneous coronary intervention can be challenging. We assessed the clinical safety of bare-metal stent implantation followed by drug-coated balloon...
Prolonged dual-antiplatelet therapy in high bleeding risk (HBR) patients undergoing percutaneous coronary intervention can be challenging. We assessed the clinical safety of bare-metal stent implantation followed by drug-coated balloon...
Prolonged dual-antiplatelet...
03/28/2019
Journal of Invasive Cardiology